HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Simply White $50 Mil. U.S. Sales Predicted By CEO Mark

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive's Simply White whitening entry is expected to generate $50 mil. in U.S. sales in its first year on shelves, CEO Reuben Mark said during a sales and earnings call July 23

You may also be interested in...



Colgate To Combat “Loss Of Focus” With Emphasis On Core

Colgate-Palmolive plans to scale back U.S. marketing spend on its Simply White tooth whitener after sales fell short of 2003 projections, CEO Reuben Mark said during a year-end financial presentation Feb. 3

Colgate To Combat “Loss Of Focus” With Emphasis On Core

Colgate-Palmolive plans to scale back U.S. marketing spend on its Simply White tooth whitener after sales fell short of 2003 projections, CEO Reuben Mark said during a year-end financial presentation Feb. 3

Marketing In Brief

Colgate: Simply White home tooth whitening entry will be supported with $60 mil. introductory ad campaign, Colgate-Palmolive says. Ad budget marks largest spend level for Colgate launch since debut of Colgate Total toothpaste in 1998, company adds. Firm plans to push up advertising start date due to "extraordinary" demand from retailers. Simply White will compete with Procter & Gamble's Crest Whitestrips as a lower priced alternative (1"The Rose Sheet" May 13, 2002, p. 5). Product is expected to generate $50 mil. in first-year U.S. sales (2"The Rose Sheet" July 29, 2002, p. 7)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel